Pluristem Therapeutics's (PSTI) shares are halted after it says that the FDA has suspended the...


Pluristem Therapeutics's (PSTI) shares are halted after it says that the FDA has suspended the Phase II trial of the company's placenta-based cell treatment for artery disease following "a serious allergic reaction" that caused the patient to be hospitalized. The patient has multiple diseases, "which may have influenced the severity of the event," and was discharged from hospital the following day. Shares are due to resume trading at 9:45. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs